SG Americas Securities, LLC
Broker-DealerPosition in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 1313360
NEW YORK, NY
Position in RYTM
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,368,602
+$737,045 QoQ
Shares Held
21,333
+13.7% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#127
of 299 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. RYTM ranks #34 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in RYTM
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,368,602 | 21,333 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,631,557 | 18,760 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,256,756 | 11,741 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $1,974,758 | 19,554 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $390,830 | 6,185 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,041,760 | 19,667 | Shares | Sole | 2025-04-15 | |
| 2024-09-30 | $393,920 | 7,519 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $1,384,830 | 33,727 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $325,538 | 7,513 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $344,775 | 7,500 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,028,736 | 44,874 | Shares | Sole | 2023-10-13 | |
| 2022-06-30 | $332,265 | 80,064 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $981,296 | 85,182 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $914,756 | 91,659 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,427,497 | 109,303 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,602,975 | 81,868 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,845,895 | 86,784 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,290,754 | 110,688 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,956,757 | 90,298 | Shares | Sole | 2020-11-09 | |
| 2020-03-31 | $173,234 | 11,382 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||